Site #058 — Detroit, Michigan

Site #058 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Site #058 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Ductal Adenocarcinoma.

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #058?

Site #058 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #058 conducted?

Site #058 has 1 clinical trials on record. Their work covers Metastatic Pancreatic Ductal Adenocarcinoma.

Is Site #058 accredited by Crixeo Health?

Site #058 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #058?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.